1. MARKETS
  2. SECTOR : COMMERCIAL SERVICES & SUPPLIES
  3. INDUSTRY : MISCELLANEOUS COMMERCIAL SERVICES
  4. RALLYBIO CORP

Rallybio Corp

XNAS: RLYB

Download real time

0.66 0.02 (3.12%)

New 52W Low in past week

19,249 XNAS Volume

XNAS 18 Mar, 2025 11:55 AM (EDT)

Watchlist

Portfolio

Share
1S
11W
6O
0T
27.4

Market Cap

Low in industry
-0.5

PE TTM

Negative PE TTM
0

PEG TTM

0.4

Price to Book

Low in industry
0

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Rallybio Corp is on 26 Mar 2025 for the purpose of Rallybio Corp Annual Report for 2024 See details


Insider Trading disclosures for Rallybio Corp

The latest disclosure was made by Steven Ryder in Rallybio Corp where a trade of 180,000 Option (Right to Buy) done was reported to US exchanges on Feb. 14, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Steven Ryder Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 180,000 180,000 - - Option (Right to Buy)
Stephen Uden Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 453,700 453,700 - - Option (Right to Buy)
Jonathan I. Lieber Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 180,000 180,000 - - Option (Right to Buy)
Hui Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 67,857 67,857 - - Option (Right to Buy)
Robert Hopfner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 73,571 73,571 - - Option (Right to Buy)
Ronald M. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 73,571 73,571 - - Option (Right to Buy)
Martin W. Mackay Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 92,857 92,857 - - Option (Right to Buy)
Helen M. Boudreau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 16,500 16,500 - - Option (Right to Buy)
Ronald M. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 16,500 16,500 - - Option (Right to Buy)
Robert Hopfner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 16,500 16,500 - - Option (Right to Buy)
Christine A. Nash Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 16,500 16,500 - - Option (Right to Buy)
Paula Soteropoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 16,500 16,500 - - Option (Right to Buy)
Hui Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 16,500 16,500 - - Option (Right to Buy)
Kush M. Parmar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 16,500 16,500 - - Option (Right to Buy)
Wendy K. Chung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2024 16,500 16,500 - - Option (Right to Buy)
Steven Ryder Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2024 120,000 120,000 - - Option (Right to Buy)
Mackay W. Martin Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2024 216,000 216,000 - - Option (Right to Buy)
Uden Stephen Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2024 216,000 216,000 - - Option (Right to Buy)
I. Lieber Jonathan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2024 120,000 120,000 - - Option (Right to Buy)
Ronald Hunt M. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 29,096 29,096 - - Option (Right to Buy)
M. Kush Parmar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 27,118 27,118 - - Option (Right to Buy)
Jonathan I. Lieber See Remarks Purchase of securities on an exchange or from another person at price $ 5.21 per share. 14 Mar 2023 5,000 5,000 - 5.2 26,050 Common Stock
Kush M. Parmar Director Sale of securities on an exchange or to another person at price $ 8.20 per share. 07 Mar 2023 100,000 2,378,969 - 8.2 820,000 Common Stock
Martin W. Mackay Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 214,000 214,000 - - Option (Right to Buy)
Stephen Uden See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 214,000 214,000 - - Option (Right to Buy)
Steven Ryder Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2023 119,000 119,000 - - Option (Right to Buy)
Jonathan I. Lieber See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 240,000 240,000 - - Option (Right to Buy)
Kush M. Parmar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 10,344 10,344 - - Option (Right to Buy)
Hui Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 10,237 10,237 - - Option (Right to Buy)
Ronald M. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 11,099 11,099 - - Option (Right to Buy)
Wendy K. Chung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 9,482 9,482 - - Option (Right to Buy)
Wendy K. Chung Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 26,880 26,880 - - Option (Right to Buy)
Kush M. Parmar Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 12.50 per share. 03 Jun 2022 99,671 2,478,969 - 12.5 1,245,888 Common Stock
Kush M. Parmar Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 12.50 per share. 03 Jun 2022 50,329 1,251,755 - 12.5 629,113 Common Stock
Kush M. Parmar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 13,440 13,440 - - Option (Right to Buy)
Hui Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 2,240 2,240 - - Option (Right to Buy)
Helen M. Boudreau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 13,440 13,440 - - Option (Right to Buy)
Paula Soteropoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 13,440 13,440 - - Option (Right to Buy)
Christine A. Nash Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 2,240 2,240 - - Option (Right to Buy)
Robert Hopfner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 13,440 13,440 - - Option (Right to Buy)
Ronald M. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 13,440 13,440 - - Option (Right to Buy)
Kush M. Parmar Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 13.00 per share. 23 May 2022 33,553 1,302,084 - 13 436,189 Common Stock
Kush M. Parmar Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 13.00 per share. 23 May 2022 66,447 2,578,640 - 13 863,811 Common Stock
Christine A. Nash Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2022 26,880 26,880 - - Option (Right to Buy)
Hui Liu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2022 26,880 26,880 - - Option (Right to Buy)
Jeffrey M. Fryer See Remarks Purchase of securities on an exchange or from another person at price $ 8.04 per share. 21 Mar 2022 3,000 47,048 - 8.0 24,120 Common Stock
Kush M. Parmar Director Sale of securities on an exchange or to another person at price $ 13.05 per share. 08 Feb 2022 139,539 2,645,087 - 13.1 1,820,984 Common Stock
Kush M. Parmar Director Sale of securities on an exchange or to another person at price $ 13.05 per share. 08 Feb 2022 70,461 1,335,637 - 13.0 919,516 Common Stock
Steven Ryder Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2022 62,000 62,000 - - Option (Right to Buy)
Jeffrey M. Fryer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2022 62,000 62,000 - - Option (Right to Buy)
Stephen Uden See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2022 62,000 62,000 - - Option (Right to Buy)
Martin W. Mackay Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2022 62,000 62,000 - - Option (Right to Buy)
Robert Hopfner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 6,242 6,242 - - Option (Right to Buy)
Paula Soteropoulos Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 5,369 5,369 - - Option (Right to Buy)
Kush M. Parmar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 5,772 5,772 - - Option (Right to Buy)
Timothy M. Shannon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 6,041 6,041 - - Option (Right to Buy)
Ronald M. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 6,242 6,242 - - Option (Right to Buy)
Ronald M. Hunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2021 13,440 13,440 - - Option (Right to Buy)
Timothy M. Shannon Director Purchase of securities on an exchange or from another person at price $ 13.00 per share. 28 Jul 2021 76,923 2,409,712 - 13 999,999 Common Stock
Ronald M. Hunt Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 2,157,838 0 - - Series B Preferred Units
Ronald M. Hunt Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 8,742,654 0 - - Series A-2 Preferred Units
Ronald M. Hunt Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 1,795,946 0 - - Series A-1 Preferred Units
Ronald M. Hunt Director Purchase of securities on an exchange or from another person at price $ 13.00 per share. 28 Jul 2021 153,846 2,147,757 - 13 1,999,998 Common Stock
Ronald M. Hunt Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 1,993,911 1,993,911 - - Common Stock
Ronald M. Hunt Director Purchase of securities on an exchange or from another person at price $ 13.00 per share. 28 Jul 2021 153,846 2,301,603 - 13 1,999,998 Common Stock
Timothy M. Shannon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2021 13,440 13,440 - - Option (Right to Buy)
Timothy M. Shannon Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 4,315,676 0 - - Series B Preferred Units
Timothy M. Shannon Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 8,742,654 0 - - Series A-2 Preferred Units
Timothy M. Shannon Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 1,795,946 0 - - Series A-1 Preferred Units
Robert Hopfner Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 1,694,388 1,694,388 - - Common Stock
Robert Hopfner Director Purchase of securities on an exchange or from another person at price $ 13.00 per share. 28 Jul 2021 576,923 2,267,411 - 13 7,499,999 Common Stock
Robert Hopfner Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 10,789,193 0 - - Series B Preferred Units
Robert Hopfner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2021 13,440 13,440 - - Option (Right to Buy)
Kush M. Parmar Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 2,784,626 2,784,626 - - Common Stock
Kush M. Parmar Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 790,714 790,714 - - Common Stock
Kush M. Parmar Director Purchase of securities on an exchange or from another person at price $ 13.00 per share. 28 Jul 2021 615,384 1,406,098 - 13 7,999,992 Common Stock
Kush M. Parmar Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 1,795,946 0 - - Series A-1 Preferred Units
Kush M. Parmar Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 8,742,654 0 - - Series A-2 Preferred Units
Kush M. Parmar Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 7,192,795 0 - - Series B Preferred Units
Kush M. Parmar Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 5,034,955 0 - - Series B Preferred Units
Kush M. Parmar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jul 2021 13,440 13,440 - - Option (Right to Buy)
Timothy M. Shannon Director Other type of transaction at price $ 0.00 per share. 28 Jul 2021 2,332,789 2,332,789 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters